A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...

Brain health advocates share tips for detecting Alzheimer’s Disease early, including tests and early signs. Plus, prevention ...

Alzheimer’s is a complex disease caused by many interacting factors. It’s possible the herpes virus could play a small role – ...

The approval comes as two Alzheimer's drugs—lecanemab and donanemab—are already authorized by the FDA. Both are antibody therapies that target amyloid plaques and are believed to be more effective ...

In a statement posted by the Massachusetts Institute of Technology Monday, researchers said they have used data about fruit ...

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...

Alzheimer’s is the seventh-leading cause of death among US adults, with the average patient living four to eight years after diagnosis.

Artificial intelligence has played a pivotal role in uncovering a potential trigger for Alzheimer’s disease and identifying a promising treatment. Researchers at the University of California, San ...

A report found that the world's youngest Alzheimer's patient is actually a 19-year-old boy. He first started showing signs at ...

Researchers at the University of São Paulo (USP) in Brazil have succeeded in showing, in an animal model, that the process of ...

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...